The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
PHOTOS: Michigan expanding the use of monoclonal antibody therapy in the fight against COVID-19
April 14, 2021
FOR IMMEDIATE RELEASE
April 14, 2021
Media Contact: Press@Michigan.gov
PHOTOS: Michigan expanding the use of monoclonal antibody therapy in the fight against COVID-19
Therapeutic treatments can help reduce symptoms in patients, risk of hospitalization and death
LANSING, Mich. -- Governor Gretchen Whitmer and Michigan Department of Health and Human Services (MDHHS) Chief Medical Executive Dr. Joneigh Khaldun provided an update on COVID-19 cases, vaccines and variants and discussed the state's efforts to expand the use of monoclonal antibody therapy to help those diagnosed with COVID-19 avoid hospitalization.
The Governor praised progress on vaccinations and urged Michiganders to keep doing their part by wearing masks, washing their hands, social distancing, and getting vaccinated. The Governor stressed there are still public health laws in place to mitigate the spread of COVID including a mask mandate, capacity limits on indoor gatherings, and mandatory testing for sports. The Governor also shared information about the use of Regeneron and Eli Lilly monoclonal antibody treatments. These treatments have been authorized for emergency use by the FDA and can be effective in preventing hospitalizations and deaths for those diagnosed with COVID-19. The state is ensuring providers across the state have the supplies they need to effectively treat Michiganders.
To view the PowerPoint presentation that the governor used during today's press conference, click the link below:
See below for photos from today's press conference:
###
|